Showing results (1421-1430 of 2,907) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|March 23, 2025
Therapeutic potential of synthetic microRNA mimics based on the miR-15/107 consensus sequenceGlen Reid, Marissa Williams, Yuen Yee Cheng, et al.Cancer Gene Therapy|July 20, 2024
NF-κB role on tumor proliferation, migration, invasion and immune escapeAfrasyab Khan, Yao Zhang, Ningna Ma, et al.Cancer Gene Therapy|May 27, 2024
Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of m6A-modified PTEN mRNA in pancreatic ductal adenocarcinomaDandan Zheng, Wenying Chen, Juanfei Peng, et al.Cancer Gene Therapy|June 26, 2024
Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse modelFei Wang, Shuo Zhang, Fengjiao Sun, et al.Cancer Gene Therapy|June 25, 2024
Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivoLéa Ikhlef, Nina Ratti, Stéphanie Durand, et al.Cancer Gene Therapy|December 3, 2025
AP-1 promotes oncogenic transcription in lung cancer cells by bridging promoter-enhancer interactionsXianglong Tan, Michael Kroneberg, Fei Sun, et al.Cancer Gene Therapy|November 22, 2025
Targeted suppression of tumor growth by CREPT promoter-driven diphtheria toxin fragment AJingya Li, Mengdi Li, Wenchen Wang, et al.Cancer Gene Therapy|April 17, 2024
miR-124-3p and miR-194-5p regulation of the PI3K/AKT pathway via ROR2 in medulloblastoma progressionChen Wang, Runxi Fu, Yunkun Wang, et al.Cancer Gene Therapy|January 4, 2024
Targeting paraptosis in cancer: opportunities and challengesFangquan Chen, Hu Tang, Xiutao Cai, et al.Cancer Gene Therapy|December 25, 2023
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumorsAnthony P Conley, Christina L Roland, Alberto Bessudo, et al.Pageof 291